prikaz prve stranice dokumenta Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine
Rad dostupan nakon 2025-03-01
Stručni rad - Pismo uredniku
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine
Annals of Hematology, 103 (2023), 2; 671-672. https://doi.org/10.1007/s00277-023-05529-3
Lucijanić, Marko; Tomasović-Lončarić, Čedna; Štoos-Veić, Tajana; De Both, Tomislav; Jalšenjak, Barbara; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Tomasović Lončarić, Č., Štoos Veić, T., De Both, T., Jalšenjak, B. i Kušec, R. (2023). Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine. Annals of Hematology, 103. (2), 671-672. doi: 10.1007/s00277-023-05529-3

Lucijanić, Marko, et al. "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine." Annals of Hematology, vol. 103, br. 2, 2023, str. 671-672. https://doi.org/10.1007/s00277-023-05529-3

Lucijanić, Marko, Čedna Tomasović Lončarić, Tajana Štoos Veić, Tomislav De Both, Barbara Jalšenjak i Rajko Kušec. "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine." Annals of Hematology 103, br. 2 (2023): 671-672. https://doi.org/10.1007/s00277-023-05529-3

Lucijanić, M., et al. (2023) 'Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine', Annals of Hematology, 103(2), str. 671-672. doi: 10.1007/s00277-023-05529-3

Lucijanić M, Tomasović Lončarić Č, Štoos Veić T, De Both T, Jalšenjak B, Kušec R. Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine. Annals of Hematology [Internet]. 02.2023. [pristupljeno 12.10.2024.];103(2):671-672. doi: 10.1007/s00277-023-05529-3

M. Lucijanić, Č. Tomasović Lončarić, T. Štoos Veić, T. De Both, B. Jalšenjak i R. Kušec, "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine", Annals of Hematology, vol. 103, br. 2, str. 671-672, Veljača 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:998089. [Citirano: 12.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:998089
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine
AutorMarko Lucijanić
AutorČedna Tomasović-Lončarić
AutorTajana Štoos-Veić
AutorTomislav De Both
MBZ: 155550
AutorBarbara Jalšenjak
AutorRajko Kušec
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Pismo uredniku
Status objaveObjavljen
Vrsta recenzijeNije recenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaAnnals of Hematology
Brojčani podacivol. 103, br. 2, str. 671-672
p-ISSN0939-5555
e-ISSN1432-0584
DOIhttps://doi.org/10.1007/s00277-023-05529-3
URN:NBNurn:nbn:hr:105:998089
Datum objave publikacije2023-02
URL dokumentahttps://link.springer.com/10.1007/s00277-023-05529-3
Vrsta resursaTekst
Prava pristupaPristup ograničen embargom
Datum isteka embarga: 2025-03-01
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-05-06 07:45:01